Epstein David R

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
15-Dec-23 6:29 PM
View: 
Seattle Genetics Inc. (SGEN) 14-Dec-23Disposition 16,407$229.00$3,757,200.00(100%)
16.41K to 0
13-Nov-23 8:02 PM
View: 
Seattle Genetics Inc. (SGEN) 10-Nov-23Private Sale (Planned) 10,620$213.01$2,262,170.00(7%)
147.22K to 136.6K
17-Aug-23 9:14 PM
View: 
Seattle Genetics Inc. (SGEN) 15-Aug-23Grant 39,650----37%
107.57K to 147.22K
14-Nov-22 5:45 PM
View: 
Seattle Genetics Inc. (SGEN) 09-Nov-22Grant 107,389----100%
0 to 107.39K
30-Jun-22 4:52 PM
View: 
Evelo Biosciences, Inc. (EVLO) 30-Jun-22Option Exercise 4,927----6%
89.0K to 93.93K
10-Jun-22 9:22 PM
View: 
Senti Biosciences, Inc. (SNTI) 08-Jun-22Grant 112,519----1048%
10.73K to 123.25K
01-Jun-22 4:12 PM
View: 
Evelo Biosciences, Inc. (EVLO) 31-May-22Option Exercise 4,925----6%
84.08K to 89.0K
31-May-22 4:07 PM
View: 
Evelo Biosciences, Inc. (EVLO) 27-May-22Private Purchase 17,123$1.46$24,999.6026%
66.96K to 84.08K
03-Jun-22 4:30 PM
View: 
Axcella Health Inc. (AXLA) 19-May-22Grant 47,059----29%
162.7K to 209.76K
02-May-22 4:03 PM
View: 
Evelo Biosciences, Inc. (EVLO) 02-May-22Option Exercise 4,926----8%
62.03K to 66.96K
22-Apr-22 6:07 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 21-Apr-22Private Purchase 30,000$1.44$43,329.00< 1%
4.69M to 4.72M
01-Apr-22 4:05 PM
View: 
Evelo Biosciences, Inc. (EVLO) 31-Mar-22Option Exercise 4,926----9%
57.1K to 62.03K
21-Mar-22 4:30 PM
View: 
Axcella Health Inc. (AXLA) 18-Mar-22Option Exercise 1,535----< 1%
161.16K to 162.7K
18-Mar-22 8:30 AM
View: 
Axcella Health Inc. (AXLA) 16-Mar-22Market Purchase 26,178$1.91$50,000.0019%
134.98K to 161.16K
3%
01-Mar-22 4:07 PM
View: 
Evelo Biosciences, Inc. (EVLO) 28-Feb-22Option Exercise 4,926----9%
52.18K to 57.1K
23-Feb-22 4:19 PM
View: 
Axcella Health Inc. (AXLA) 18-Feb-22Option Exercise 1,534----1%
133.45K to 134.98K
31-Jan-22 5:06 PM
View: 
Evelo Biosciences, Inc. (EVLO) 31-Jan-22Option Exercise 4,925----10%
47.25K to 52.18K
20-Jan-22 4:30 PM
View: 
Axcella Health Inc. (AXLA) 18-Jan-22Option Exercise 1,535----1%
131.91K to 133.45K
03-Jan-22 4:23 PM
View: 
Evelo Biosciences, Inc. (EVLO) 31-Dec-21Option Exercise 4,926----12%
42.33K to 47.25K
20-Dec-21 4:15 PM
View: 
Axcella Health Inc. (AXLA) 17-Dec-21Option Exercise 1,535----1%
130.38K to 131.91K
01-Dec-21 4:39 PM
View: 
Evelo Biosciences, Inc. (EVLO) 30-Nov-21Option Exercise 4,926----13%
37.4K to 42.33K
22-Nov-21 6:04 PM
View: 
Axcella Health Inc. (AXLA) 18-Nov-21Option Exercise 1,534----1%
128.85K to 130.38K
01-Nov-21 5:22 PM
View: 
Evelo Biosciences, Inc. (EVLO) 01-Nov-21Option Exercise 4,925----15%
32.48K to 37.4K
19-Oct-21 4:31 PM
View: 
Axcella Health Inc. (AXLA) 18-Oct-21Option Exercise 1,535----1%
127.31K to 128.85K
01-Oct-21 4:42 PM
View: 
Evelo Biosciences, Inc. (EVLO) 01-Oct-21Option Exercise 4,927----18%
27.55K to 32.48K
20-Sep-21 4:31 PM
View: 
Axcella Health Inc. (AXLA) 17-Sep-21Option Exercise 1,535----1%
125.78K to 127.31K
03-Sep-21 4:55 PM
View: 
Evelo Biosciences, Inc. (EVLO) 03-Sep-21Option Exercise 9,850----56%
17.7K to 27.55K
20-Jul-21 4:31 PM
View: 
Axcella Health Inc. (AXLA) 16-Jul-21Option Exercise 1,535----1%
122.71K to 124.24K
21-Jun-21 5:42 PM
View: 
Axcella Health Inc. (AXLA) 18-Jun-21Option Exercise 1,535----1%
121.17K to 122.71K
20-May-21 4:31 PM
View: 
Axcella Health Inc. (AXLA) 18-May-21Option Exercise 1,534----1%
119.64K to 121.17K
20-Apr-21 4:58 PM
View: 
Axcella Health Inc. (AXLA) 18-Apr-21Option Exercise 1,535----1%
118.1K to 119.64K
16-Feb-21 9:51 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 11-Feb-21Market Sale (Planned) 26,704$14.93$398,560.00(< 1%)
4.72M to 4.69M
13%
10-Feb-21 9:12 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 10-Feb-21Market Sale (Planned) 7,404$14.79$109,525.00(< 1%)
4.72M to 4.72M
3%
10-Feb-21 9:12 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 09-Feb-21Market Sale (Planned) 2,100$14.83$31,145.90(< 1%)
4.73M to 4.72M
3%
10-Feb-21 9:12 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 08-Feb-21Market Sale (Planned) 89,233$14.88$1,328,120.00(2%)
4.82M to 4.73M
3%
14-Dec-20 5:15 PM
View: 
Evelo Biosciences, Inc. (EVLO) 11-Dec-20Market Purchase 7,700$6.66$51,260.8077%
10.0K to 17.7K
61%
01-Sep-20 4:13 PM
View: 
Evelo Biosciences, Inc. (EVLO) 31-Aug-20Market Purchase 5,752$4.49$25,803.90135%
4.25K to 10.0K
139%
01-Sep-20 4:13 PM
View: 
Evelo Biosciences, Inc. (EVLO) 28-Aug-20Market Purchase 4,248$4.39$18,631.20100%
0 to 4.25K
145%
20-May-20 4:07 PM
View: 
Axcella Health Inc. (AXLA) 18-May-20Purchase 50,000$4.75$237,500.0073%
68.1K to 118.1K
19-Mar-20 6:34 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 17-Mar-20Market Purchase 5,000$3.76$18,800.00< 1%
4.81M to 4.82M
282%
17-Mar-20 5:59 PM
View: 
Rubius Therapeutics, Inc. (RUBY) 13-Mar-20Market Purchase 10,000$3.91$39,100.00< 1%
4.8M to 4.81M
267%
02-Mar-20 7:04 PM
View: 
Axcella Health Inc. (AXLA) 28-Feb-20Market Purchase 2,005$3.75$7,518.753%
66.1K to 68.1K
02-Mar-20 7:04 PM
View: 
Axcella Health Inc. (AXLA) 27-Feb-20Market Purchase 12,800$3.65$46,720.0024%
53.3K to 66.1K
02-Dec-19 7:31 PM
View: 
Axcella Health Inc. (AXLA) 27-Nov-19Market Purchase 1,005$3.91$3,929.552%
52.29K to 53.3K
03-Dec-19 11:20 AM
View: 
Axcella Health Inc. (AXLA) 27-Nov-19Market Purchase
Duplicate
1,005$3.91$3,929.552%
52.29K to 53.3K
02-Dec-19 7:31 PM
View: 
Axcella Health Inc. (AXLA) 26-Nov-19Market Purchase 14,000$3.55$49,700.0037%
38.29K to 52.29K
03-Dec-19 11:20 AM
View: 
Axcella Health Inc. (AXLA) 26-Nov-19Market Purchase
Duplicate
14,000$3.55$49,700.0037%
38.29K to 52.29K
05-Aug-19 4:55 PM
View: 
Axcella Health Inc. (AXLA) 02-Aug-19Market Purchase 2,849$7.04$20,057.008%
35.44K to 38.29K
05-Aug-19 4:55 PM
View: 
Axcella Health Inc. (AXLA) 01-Aug-19Market Purchase 4,092$6.98$28,562.2013%
31.35K to 35.44K
18-Jul-19 9:54 PM
View: 
Axcella Health Inc. (AXLA) 17-Jul-19Market Purchase 1,000$7.55$7,550.003%
30.35K to 31.35K